Isolated recurrent myelitis in a 7-year-old child with serum aquaporin-4 IgG antibodies
暂无分享,去创建一个
[1] V. Damato,et al. Efficacy and Safety of Rituximab Therapy in Neuromyelitis Optica Spectrum Disorders: A Systematic Review and Meta-analysis. , 2016, JAMA neurology.
[2] C. Tan. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders , 2016, Neurology.
[3] M. Nolan,et al. Rituximab monitoring and redosing in pediatric neuromyelitis optica spectrum disorder , 2016, Neurology: Neuroimmunology & Neuroinflammation.
[4] M. Filippi,et al. Rituximab as a first-line preventive treatment in pediatric NMOSDs , 2014, Neurology: Neuroimmunology & Neuroinflamm.
[5] R. Zivadinov,et al. Conventional and Advanced Imaging in Neuromyelitis Optica , 2014, American Journal of Neuroradiology.
[6] S. Tenembaum. Treatment of multiple sclerosis and neuromyelitis optica in children and adolescents , 2013, Clinical Neurology and Neurosurgery.
[7] Jacqueline A Palace,et al. The differential diagnosis of longitudinally extensive transverse myelitis , 2012, Multiple sclerosis.
[8] B. Weinshenker,et al. CNS aquaporin-4 autoimmunity in children , 2008, Neurology.
[9] B. Weinshenker,et al. The spectrum of neuromyelitis optica , 2007, The Lancet Neurology.